Literature DB >> 14581261

Possible differences between fibrates in pharmacokinetic interactions with statins.

Christie M Ballantyne, Michael H Davidson.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14581261     DOI： 10.1001/archinte.163.19.2394

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  4 in total

1.  Achieving American Diabetes Association goals in HIV-seropositive patients with diabetes mellitus.

Authors:  John E Bury; Jeffrey S Stroup; Johnny R Stephens; Damon L Baker
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

Review 2.  Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib.

Authors:  Marta A Miyares; Kyle Davis
Journal:  Vasc Health Risk Manag       Date:  2012-08-23

3.  Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy.

Authors:  Mohsen Zabihi; Fatemeh Askarian; Seyedhossein Hekmatimoghaddam; Mohammadreza Rashidi Nooshabadi; Mohammad Sajjad Zabihi; Seyed Ruhollah Mousavinasab
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-12-29

4.  Tendon rupture associated with concomitant simvastatin and gemfibrozil use: Biological and pharmacokinetic implications.

Authors:  Edison Jose Cano Cevallos; Danial Haris Shaikh; Jose Gonzalez; William Sanchez; Madanmohan Patel
Journal:  Clin Case Rep       Date:  2019-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.